Country Icon

PDL BioPharma, Inc. (PDLI) - Buy, Sell or Hold?

Sector: Health Care   Sub-Sector: Biotechnology: Biological Products (No Diagnostic Substances)
Trade DateCurrent Candlestick PatternPrevious Candlestick PatternWhenPerformance Since
Tue, 19 Aug 2014NoneBullish EngulfingTue, 05 Aug 20141.6%
***Stock database and scans are updated around midnight (New York time) every trading day.
9.55 0.23 (2.41%) Aug 19 4:00pm EDT
Open: 9.51 Range: 9.35 - 9.75 Vol: 3.7M Avg Vol: 2.16M
EPS: 1.74 P/E ratio: 5.37 EBITDA: 463.1M Mkt Cap: 1.534B
Analyze "PDLI" - FREE 30 Day Trial of Market Analyst 7
Short Term: Trend is Up
Last Trade is above the 5 day moving average at 9.43
Medium Term: Trend is Up
Last Trade is above the 20 day moving average at 9.40
Last Trade is above the 50 day moving average at 9.52
Long Term: Trend is Up
Last Trade is above the 200 day moving average at 8.85
* Data normalized for Splits & Dividends. Report data issues
How to use this info: Stock Timing With Moving Averages
Daily Chart of PDLI

Stock Trend Analysis - Buy, Sell or Hold "PDL BioPharma, Inc." (PDLI)?

PDLI is in a very strong uptrend. In the last 52 weeks, PDLI has been trading above the 200 day moving average for 90% of the time with an average daily volume of 2.2M shares being traded. The 50 day moving average, currently at 9.52, although still maintaining a bullish inclination, is however exhibiting characteristics of a medium term trading range. As the dominant long term trend is still up strongly, the high probability trade is still buying the dips. The 20 day moving average is in a trading range and is generally bucking the trend with a bearish bias. PDLI was only able to maintain above the 20 SMA for 35% of the time in the last month of trading. Objectively, in a strong uptrend, the high probability strategy is to buy dips. Traders who are thinking of going long PDLI shares should consider patiently waiting for price to be near the 50 or 200 SMAs, currently at 9.52 and 8.85 respectively. Click here for the latest support & resistance levels to help you finetune your entry into or exit out of "PDLI".

The analyst consensus estimates for the 1 year price target for this stock is $7.33* (*source: Yahoo Finance).

Objective Technical Analysis by BannRonn TA LogicEngine ver 1.1. Last Updated - Tue, 19 Aug 2014
Health Care Stocks Above 200 Day Moving-Average
TickerNameTrend AnalysisSupport/Resistance
EXACExactech, Inc.Buy, Sell or HoldTrading Levels & Pivots
CFNCareFusion CorporationBuy, Sell or HoldTrading Levels & Pivots
RMDResMed Inc.Buy, Sell or HoldTrading Levels & Pivots
NBIXNeurocrine Biosciences, Inc.Buy, Sell or HoldTrading Levels & Pivots
OFIXOrthofix International N.V.Buy, Sell or HoldTrading Levels & Pivots
BRLIBio-Reference Laboratories, Inc.Buy, Sell or HoldTrading Levels & Pivots
BIIBBiogen Idec IncBuy, Sell or HoldTrading Levels & Pivots
DXCMDexCom, Inc.Buy, Sell or HoldTrading Levels & Pivots
PETSPetMed Express, Inc.Buy, Sell or HoldTrading Levels & Pivots
CRLCharles River Laboratories International, Inc.Buy, Sell or HoldTrading Levels & Pivots